e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Respiratory epidemiology: quality of life, therapy and socioeconomics
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Productivity loss in ever-smoking COPD subjects from a general population
R. Nielsen, A. Johannessen, P. S. Bakke, E. R. Omenaas, A. Gulsvik (Bergen, Norway)
Source:
Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Session:
Respiratory epidemiology: quality of life, therapy and socioeconomics
Session type:
Thematic Poster Session
Number:
4128
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Nielsen, A. Johannessen, P. S. Bakke, E. R. Omenaas, A. Gulsvik (Bergen, Norway). Productivity loss in ever-smoking COPD subjects from a general population. Eur Respir J 2011; 38: Suppl. 55, 4128
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Quantifying comorbidity in individuals with COPD: a population study
Source: Eur Respir J 2015; 45: 51-59
Year: 2015
Prevalence of COPD in a general population
Source: Eur Respir J 2005; 26: Suppl. 49, 593s
Year: 2005
Incidence of asthma and COPD in a general population
Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD
Year: 2010
The population attributable fraction of occupational COPD among Danish women
Source: ERJ Open Res, 3 (2) 00075-2016; 10.1183/23120541.00075-2016
Year: 2017
Only severe COPD is associated with being underweight: results from a population survey
Source: ERJ Open Res 2016: 00051-2015
Year: 2016
An observational study of age-related smoking status in COPD patients stratified by severity of airflow obstruction
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
Smoking reduction and hospitalization from COPD: a Danish population study
Source: Eur Respir J 2001; 18: Suppl. 33, 484s
Year: 2001
Health indicators and inflammation - a comparison of stable smoking and ex-smoking COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005
Prevalence of COPD and comorbidities in non-smoking women- results from two cohorts studies
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016
Lung core-predominant emphysema is associated with higher symptom burden in COPD: analysis of the COPDGene cohort
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017
Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021
Year: 2021
Impact of chronic cough in individuals with COPD: a population-based cohort study
Source: International Congress 2019 – More and more COPD
Year: 2019
Prevalence of COPD in a general practice population
Source: Eur Respir J 2005; 26: Suppl. 49, 591s
Year: 2005
Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Smoking and BMI in COPD and non-COPD patients
Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals
Year: 2021
Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Motivation of smokers and patients with smoking related diseases: the case of COPD
Source: ERS Course 2015
Year: 2015
Prevalence of common diseases in COPD patients versus lung-healthy control subjects: Results from the German COSYCONET study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept